Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032
ch14.18(Dinutuximab)+细胞因子免疫疗法治疗高危神经母细胞瘤患儿的III期研究的长期随访:COG研究ANBL0032
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-3909
Yu, Alice L; Gilman, Andrew L; Ozkaynak, M Fevzi; Naranjo, Arlene; Diccianni, Mitchell B; Gan, Jacek; Hank, Jacquelyn A; Batova, Ayse; London, Wendy B; Tenney, Sheena C; Smith, Malcolm; Shulkin, Barry L; Parisi, Marguerite; Matthay, Katherine K; Cohn, Susan L; Maris, John M; Bagatell, Rochelle; Park, Julie R; Sondel, Paul M